Company / Operating Income
Embecta Corp. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$242.1M
FY2025
5-year range
$166.8M / $492.0M
FY2021-FY2025
Trend
+45.1%
vs FY2024
Sector context
#56 of 156
Health Care
What the data says
At $242M, Embecta Corp.'s operating income ranks #56 of 156 in the Health Care sector. Operating Income returned to growth in FY2025 after 3 years of decline, reaching $242M.
Based on SEC 10-K filings.
$242M in FY2025 with a 5-year CAGR of -13.0%.
Improved from $222M to $242M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -20.8%
- 5-Year CAGR
- -13.0%
- 10-Year CAGR
- -
Sector benchmark
#56 of 156 in Health CareTop 36% of 156This company $242.1M Sector average $733.1M
▼
-67.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -13.0%, indicating a declining trend.
- In FY2025, operating income increased 45.1% year-over-year.
- Ranks #56 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $242.1M | +45.1% |
| FY2024 | $166.8M | -24.7% |
| FY2023 | $221.5M | -54.5% |
| FY2022 | $486.5M | -1.1% |
| FY2021 | $492.0M | +1.1% |
| FY2020 | $486.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026